MDA 2026 keynote speaker John Crowley discussed with MD News Today the progress made in neuromuscular disease and the future challenges.

EVE Health Group (ASX:EVE) is aiming to enter global markets estimated to exceed US$30 billion after successfully completing research and development work on several reformulated drug candidates.

NEW YORK, CA, UNITED STATES, March 9, 2026 /EINPresswire.com/ -- Crisis Text Line has partnered with Raregivers Inc, a ...

Strengthening balance sheet and capitalization is a key Jaguar priorityCompany continues its sharp, strategic focus on ...

Q4 2025 earnings call: neffy sales, payer access expansion, DTC strategy, and 2026 outlook on adoption, SG&A discipline—read now.

Key Takeaways. Section 804 creates a legal pathway for states and tribes to import certain Canadian prescription drugs, contingent on demonstrable consumer savings and adherence t ...

Olema Pharmaceuticals (OLMA) stock plummeted 41% after Roche's Phase 3 breast cancer trial failed its primary endpoint, ...

Building a big nest egg for your post-work life by buying stocks is very possible, but it requires patience, investing in the ...

Island Pharma expands antiviral pipeline with Burnet Institute; NHMRC grant of over $780k to back ISLA-101, accelerating Galidesivir MVD program.

Atea Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.57 EPS, expectations were $-0.49. Operator: ...

Although major pharmaceutical companies have fallen in line with President Donald Trump’s “most favored nation” (MFN) drug pricing agenda, the specifics of their negotiated concessions and the actu | ...

Taiwan is mapping out a four-year national pharmaceutical resilience preparedness program that aims to bolster the country’s domestic drug supply with a 24 billion new Taiwan dollar ($755 million) | ...